Complement regulators in human disease: lessons from modern genetics
- PMID: 25495259
- DOI: 10.1111/joim.12338
Complement regulators in human disease: lessons from modern genetics
Abstract
First identified in human serum in the late 19th century as a 'complement' to antibodies in mediating bacterial lysis, the complement system emerged more than a billion years ago probably as the first humoral immune system. The contemporary complement system consists of nearly 60 proteins in three activation pathways (classical, alternative and lectin) and a terminal cytolytic pathway common to all VSports手机版. Modern molecular biology and genetics have not only led to further elucidation of the structure of complement system components, but have also revealed function-altering rare variants and common polymorphisms, particularly in regulators of the alternative pathway, that predispose to human disease by creating 'hyperinflammatory complement phenotypes'. To treat these 'complementopathies', a monoclonal antibody against the initiator of the membrane attack complex, C5, has received approval for use. Additional therapeutic reagents are on the horizon. .
Keywords: age-related macular degeneration; atypical haemolytic uraemic syndrome; complement regulation; eculizumab; genetics; therapeutics V体育安卓版. .
© 2014 The Association for the Publication of the Journal of Internal Medicine. V体育ios版.
Publication types (V体育ios版)
- "V体育安卓版" Actions
MeSH terms
- "V体育官网" Actions
- V体育ios版 - Actions
- "V体育官网入口" Actions
- "V体育安卓版" Actions
- "V体育平台登录" Actions
- "V体育安卓版" Actions
- "VSports最新版本" Actions
- V体育官网 - Actions
- VSports - Actions
V体育2025版 - Substances
- "V体育2025版" Actions
- "V体育官网" Actions
- V体育官网 - Actions
Grants and funding
"V体育官网入口" LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
